Evidence map›Paper›PMID 34061896›Full record

ArticlePloS one2021

Producing molecular biology reagents without purification.

Sanchita Bhadra, Vylan Nguyen, Jose-Angel Torres, Shaunak Kar, Stéphane Fadanka, Chiara Gandini, Harry Akligoh, Inyup Paik, Andre C Maranhao, Jenny Molloy and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Expression and Engineering of Conductive Cytochrome Nanowires.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Understanding dry proteins and their protection with solid-state hydrogen-deuterium exchange.Protein science : a publication of the Protein Society · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Sanchita BhadraDepartment of Molecular Biosciences, College of Natural Sciences, The University of Texas at Austin, Austin, Texas, United States of America.ORCID 0000-0002-4956-2405
Vylan NguyenFreshman Research Initiative, DIY Diagnostics Stream, The University of Texas at Austin, Austin, Texas, United States of America.
Jose-Angel TorresFreshman Research Initiative, DIY Diagnostics Stream, The University of Texas at Austin, Austin, Texas, United States of America.
Shaunak KarDepartment of Molecular Biosciences, College of Natural Sciences, The University of Texas at Austin, Austin, Texas, United States of America.
Stéphane FadankaMboalab Biotech, Yaoundé, Cameroon.
Chiara GandiniDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.
Harry AkligohHive Biolab, Kumasi, Ghana.ORCID 0000-0002-6949-1392
Inyup PaikDepartment of Molecular Biosciences, College of Natural Sciences, The University of Texas at Austin, Austin, Texas, United States of America.ORCID 0000-0001-5938-6380
Andre C MaranhaoDepartment of Molecular Biosciences, College of Natural Sciences, The University of Texas at Austin, Austin, Texas, United States of America.
Jenny MolloyDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.
Andrew D EllingtonDepartment of Molecular Biosciences, College of Natural Sciences, The University of Texas at Austin, Austin, Texas, United States of America.
The University of Texas at Austin · USUniversity of Cambridge · GBKumasi Centre for Collaborative Research in Tropical Medicine · GH

Funding

Directed evolution of polymerases that can read and write extremely long sequencesR01EB027202 · NIBIB · UNIVERSITY OF TEXAS AT AUSTIN · PI ELLINGTON, ANDREW D · 2020 to 2024
$1.6M
NIBIB NIH HHS R01 EB027202NIH HHS 1-R01-EB027202-01A1
6 · The paper itself

Abstract

We recently developed 'cellular' reagents-lyophilized bacteria overexpressing proteins of interest-that can replace commercial pure enzymes in typical diagnostic and molecular biology reactions. To make cellular reagent technology widely accessible and amenable to local production with minimal instrumentation, we now report a significantly simplified method for preparing cellular reagents that requires only a common bacterial incubator to grow and subsequently dry enzyme-expressing bacteria at 37°C with the aid of inexpensive chemical desiccants. We demonstrate application of such dried cellular reagents in common molecular and synthetic biology processes, such as PCR, qPCR, reverse transcription, isothermal amplification, and Golden Gate DNA assembly, in building easy-to-use testing kits, and in rapid reagent production for meeting extraordinary diagnostic demands such as those being faced in the ongoing SARS-CoV-2 pandemic. Furthermore, we demonstrate feasibility of local production by successfully implementing this minimized procedure and preparing cellular reagents in several countries, including the United Kingdom, Cameroon, and Ghana. Our results demonstrate possibilities for readily scalable local and distributed reagent production, and further instantiate the opportunities available via synthetic biology in general.

Indexed as

CameroonCOVID-19COVID-19 TestingDiagnostic Tests, RoutineEscherichia coliGene ExpressionGeobacillus stearothermophilusGhanaHumansIndicators and ReagentsMolecular Diagnostic TechniquesPlasmidsReal-Time Polymerase Chain ReactionRecombinant ProteinsSARS-CoV-2Synthetic BiologyIndicators and ReagentsRecombinant Proteins

Identifiers

PMID34061896
PMCPMC8168896
OpenAlexW3165524457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.